Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of Colorado, a body”
255 pharma patents match "The Regents of the University of Colorado, a body" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 255 pharmaceutical patents matching "The Regents of the University of Colorado, a body" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10941392
Purification of cystathionine beta-synthase
granted -
US 10912770
Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances
granted -
US 10913790
Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
granted -
US 10912767
Anthracycline prodrugs and methods of making and using the same
granted -
US 10889625
Peptide-based methods for treating neurological injury
granted -
US 10874745
Antimicrobial peptides and methods of treating gram-negative pathogens: polar and non-polar face analogs
granted -
US 10857106
Methods and products for treating and/or delaying onset of dysplastic lesions
granted -
US 10799511
Methods for reducing or ameliorating mortality and/or morbidity due to chlorine inhalation
granted -
US 10791731
Methods for preparing frozen plasma material for rapid thawing in an emergency situation
granted -
US 10751408
Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
granted -
US 10736864
Immunotherapeutic agent
granted -
US 10738123
Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia
granted -
US 10729753
Compositions and methods for treatment of homocystinuria
granted -
US 10723784
Compositions and methods for preparing a subject for organ or non-organ implantation
granted -
US 10689392
Anti-cancer compounds targeting ral GTPases and methods of using the same
granted -
US 10674901
Minimally-invasive measurement of esophageal inflammation
granted -
US 10676480
Anti-cancer compounds targeting Ral GTPases and methods of using the same
granted -
US 10653755
Compositions and methods for treatment of homocystinuria
granted -
US 10624959
Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
granted -
US 10562938
Theragnostic particles
granted -
US 10548979
Light-activated compositions and methods using the same
granted -
US 10517917
Compositions and methods for preventing or treating pulmonary hypertension
granted -
US 10520517
Disease severity index for assessment of chronic liver disease
granted -
US 10519423
High efficiency reprogramming of fibroblasts into cardiomyocytes
granted